Cat. No. | Product name | CAS No. |
DCC5637 |
Zinc64700951
Novel gp120 of HIV-1 Antagonist |
|
DCC5638 |
Zinc65022200
Novel potent and specific inhibitor of the UNC119-Src interaction, binding to UNC119 in cells, and inducing redistribution of Src to endomembranes and reduction of activating Src autophosphorylation on Y419 |
|
DCC5639 |
Zinc69811181
Novel ASCT2 inhibitor |
|
DCC5640 |
Zinpyr-1
Cell-permeable fluorometric zinc sensor |
288574-78-7 |
DCC5641 |
Zk187638
Non-competitive AMPA receptor antagonist |
397298-63-4 |
DCC5642 |
Zk230211
Type III progesterone receptor antagonist with enhanced antiproliferative properties |
211254-73-8 |
DCC5643 |
Zk-304709
Novel oral multitarget tumour growth inhibitor |
1010440-84-2 |
DCC5644 |
Zk-806450
Novel potent inhibitor of factor Xa (FXa) |
|
DCC5645 |
Zl006-05
Novel dual mordulator of nNOS-PSD-95 interaction and GABA A receptor |
|
DCC5646 |
Zl0513
Novel potent and selective BRD4 bromodomain 1 (BD1) inhibitor |
2230496-92-9 |
DCC5647 |
Zl0516
Novel potent and selective BRD4 bromodomain 1 (BD1) inhibitor |
2230496-93-0 |
DCC5648 |
Zl3138
Novel β-catenin/B-cell lymphoma 9 (BCL9) inhibitor, disrupting the β-catenin/BCL9 protein-protein interaction (PPI) with a Ki of 0.96 μM and without affecting the β-catenin/E-cadherin interaction in living cells, displaying good selectivity for β-catenin/ |
|
DCC5649 |
Zld10a
Novel potent and highly selective inhibitor of wild-type and mutant versions of EZH2 |
1782064-91-8 |
DCC5650 |
Zm-181037
ATP-sensitive potassium channel-blocker; Eukalemic diuretic |
138779-29-0 |
DCC5651 |
zm-189154
Non-steroidal pure antioestrogen |
101908-22-9 |
DCC5652 |
zm-230487
5-Lipoxygenase (5-LO) inhibitor |
155944-23-3 |
DCC5653 |
Zm-244085
K-Channel opener (PCO) activating predominantly KATP channels in vitro to relax bladder detrusors |
149398-59-4 |
DCC5654 |
zm-253270
Selective nonpeptide, NK-2 receptor (NK-2R) antagonist |
169340-04-9 |
DCC5655 |
Zm-260384
Potassium channel opener |
161229-62-5 |
DCC5656 |
Zm39923 Hydrochloride
Potent, selective inhibitor of Janus tyrosine kinase 3 (JAK3) |
58753-54-1 |
DCC5657 |
Zn-htsm
Novel antidiabetic agent for the treatment of type 2 diabetes mellitus (DM) |
|
DCC5658 |
Zofenoprilat
Inducer of functional angiogenesis through increased H 2 S availability |
75176-37-3 |